Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Mixed reality therapy for improving arm and hand function in people with multiple sclerosis

Official title: Effects of Mixed Reality on Manipulative Skills, Functionality and Quality of Life in People With Multiple Sclerosis. A Randomized Controlled Trial (VIRTUAL-DOMUS)

Run by Universidad Rey Juan Carlos · NCT06968676 · Data updated 2026-11-12

This trial will try mixed‑reality training combined with conventional physiotherapy to improve upper‑limb strength, coordination, dexterity, and daily function in adults with multiple sclerosis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversidad Rey Juan Carlos
Academic / other
Locations1 site (Leganés, Madrid)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedMay 5, 2026
Trial IDNCT06968676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with multiple sclerosis for more than two years, EDSS 2.0–7.0, stable medications for at least six months, upper‑limb muscle tone ≤2 on the modified Ashworth Scale, and muscle strength ≥3 are the best candidates.

Probably not a fit

People with very advanced disability (EDSS >7.0), severe spasticity or very weak upper limbs, unstable medical treatment, or cognitive/visual problems that prevent using mixed‑reality equipment are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants receive a conventional upper‑limb physiotherapy program with or without additional mixed‑reality training set in everyday environments such as a kitchen, bathroom, living room, bedroom, and terrace‑garden. The mixed‑reality sessions are designed to retrain manipulative skills, muscle strength, coordination, dexterity, range of motion, and fatigability through repeated functional tasks with feedback. Outcomes include measures of manipulative skills, upper‑limb functionality, quality of life, muscle strength, coordination, manual dexterity, range of motion, and fatigue. The trial enrolls adults with MS (disease duration >2 years) with EDSS scores of 2.0 to 7.0 and requires stable medication and preserved upper‑limb strength and tone for safe participation.

Why it matters

Potential benefit: If successful, the approach could improve arm and hand function and quality of life by making rehabilitation more engaging and task‑specific.

How similar studies have gone: While virtual reality interventions have shown promise in neurological rehabilitation, mixed reality specifically for upper‑limb rehabilitation in MS is largely untested and this protocol is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

-\>18 years of age.

* Diagnosis of MS according to McDonald criteria (53) with a time of evolution longer than two years.
* Assessment on the Kurtzke Multiple Sclerosis Disability Status Scale (EDSS) with a score between 2. 0 (minimal disability in one section of the FS (at least one with a score of 2).) to 7.0 (unable to walk more than a few steps, even with assistance, basically confined to wheelchair and able to transfer from wheelchair to another place, or can manage to go to the toilet for 12 hours a day) .
* Stable medical treatment for at least six months prior to surgery.
* Upper extremity muscle tone no greater than 2 points (moderate hypertonia, increased muscle tone during most of the arc of motion, but can passively move the affected part with ease) on the modified Ashworth Scale.
* Muscle balance equal to or greater than 3 in the upper extremity.
* Score less than or equal to 4 points on the "Pyramidal Function" section of the EDSS functional scale.
* Absence of cognitive impairment, with ability to understand instructions and score equal to or greater than 24 on the Minimental Test.

A- score equal to or less than 2 points on the "Mental Functions" section of the EDSS.

Exclusion Criteria:

* Diagnosis of a neurological disease or musculoskeletal disorder other than MS.
* Diagnosis of a cardiovascular, respiratory or metabolic disease or other conditions that may interfere with this study.
* Having suffered an exacerbation or hospitalization in the last 3 months before starting the assessment protocol, or during the therapeutic intervention process.
* Having received a course of steroids, intravenous or oral, 6 months prior to the start of the assessment protocol and within the intervention period of the study duration.
* Having received treatment with botulinum toxin in the 6 months prior to the start of the study.
* A score higher than 2 points on the modified Ashworth scale.
* Cognitive or language impairment that prevents adequate communication or comprehension.
* The presence of visual disturbances not corrected by ocular devices; or a history of photosensitive epilepsy.

Where it's running

  • Asociación de Leganés de Esclerosis Múltiple
    Leganés, Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Roberto Cano de la Cuerda, PhD — Universidad Rey Juan Carlos
  • Study coordinator: Roberto Cano de la Cuerda, PhD
  • Email: roberto.cano@urjc.es
  • Phone: +34914888674

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.